Together, our findings support the hypothesis that hyperglucagonemia acts via adenylate cyclase to decrease hepatic GSH levels, leading to an impairment in postprandial insulin sensitivity and to overall insulin resistance, a mechanism that would account for the development of postprandial hyperglycemia and type 2 diabetes. The gene discussed is INS; the disease is Hyperglycemia.